MX379371B - Composiciones. - Google Patents
Composiciones.Info
- Publication number
- MX379371B MX379371B MX2017006168A MX2017006168A MX379371B MX 379371 B MX379371 B MX 379371B MX 2017006168 A MX2017006168 A MX 2017006168A MX 2017006168 A MX2017006168 A MX 2017006168A MX 379371 B MX379371 B MX 379371B
- Authority
- MX
- Mexico
- Prior art keywords
- hpc
- wax
- core
- delayed release
- coated tablet
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- 239000004480 active ingredient Substances 0.000 abstract 2
- 230000003111 delayed effect Effects 0.000 abstract 2
- 230000004888 barrier function Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/288—Compounds of unknown constitution, e.g. material from plants or animals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Una tableta revestida en prensa para liberación retardada de un ingrediente activo que comprende: (a) un núcleo que comprende uno o más ingredientes activos, y; (b) una barrera de liberación retardada erosionable que circunda el núcleo y que comprende una cera y dos o más grados de LHPC, en donde la cera y L-HPC se proporcionan en una relación en peso de cera a L-HPC de 30%:70% a 70%:30%. La invención también se refiere a un método para hacer la tableta revestida en prensa.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1420306.1A GB201420306D0 (en) | 2014-11-14 | 2014-11-14 | Compositions |
| PCT/GB2015/053471 WO2016075495A1 (en) | 2014-11-14 | 2015-11-16 | Composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2017006168A MX2017006168A (es) | 2017-09-12 |
| MX379371B true MX379371B (es) | 2025-03-10 |
Family
ID=52248394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017006168A MX379371B (es) | 2014-11-14 | 2015-11-16 | Composiciones. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US10675247B2 (es) |
| EP (1) | EP3217964B1 (es) |
| JP (1) | JP6774103B2 (es) |
| KR (1) | KR102253728B1 (es) |
| CN (1) | CN106999438A (es) |
| AU (1) | AU2015344838B2 (es) |
| CA (1) | CA2967738C (es) |
| DK (1) | DK3217964T3 (es) |
| ES (1) | ES2755960T3 (es) |
| GB (1) | GB201420306D0 (es) |
| HU (1) | HUE047581T2 (es) |
| MX (1) | MX379371B (es) |
| PL (1) | PL3217964T3 (es) |
| PT (1) | PT3217964T (es) |
| RU (1) | RU2717574C2 (es) |
| SA (1) | SA517381522B1 (es) |
| SI (1) | SI3217964T1 (es) |
| WO (1) | WO2016075495A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201420311D0 (en) * | 2014-11-14 | 2014-12-31 | Bio Images Drug Delivery Ltd | Pharmaceutical processing |
| CN111698983B (zh) * | 2018-01-09 | 2022-10-18 | 南京三迭纪医药科技有限公司 | 一种包含固定剂量adhd非兴奋剂和adhd兴奋剂的复方口服药物剂型 |
| WO2023214280A1 (en) * | 2022-05-06 | 2023-11-09 | Craft Health Pte Ltd | System for controllable release in 3d-printed colon targeting (corr3ct) oral dosage form |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4132753A (en) | 1965-02-12 | 1979-01-02 | American Cyanamid Company | Process for preparing oral sustained release granules |
| JPS5839618A (ja) | 1981-09-04 | 1983-03-08 | Chugai Pharmaceut Co Ltd | 持続性積層錠剤 |
| US4443428A (en) | 1982-06-21 | 1984-04-17 | Euroceltique, S.A. | Extended action controlled release compositions |
| US5026560A (en) | 1987-01-29 | 1991-06-25 | Takeda Chemical Industries, Ltd. | Spherical granules having core and their production |
| US5126145A (en) | 1989-04-13 | 1992-06-30 | Upsher Smith Laboratories Inc | Controlled release tablet containing water soluble medicament |
| EP0418596A3 (en) | 1989-09-21 | 1991-10-23 | American Cyanamid Company | Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form |
| IE61651B1 (en) | 1990-07-04 | 1994-11-16 | Zambon Spa | Programmed release oral solid pharmaceutical dosage form |
| WO1993019741A1 (en) * | 1992-03-31 | 1993-10-14 | Benzon Pharma A/S | A pharmaceutical formulation |
| JP3059004B2 (ja) * | 1992-09-18 | 2000-07-04 | ダイセル化学工業株式会社 | アルカリ水溶液に対する溶解性の高い低置換度ヒドロキシプロピルセルロース及びその製造法 |
| IL109770A0 (en) | 1993-05-29 | 1994-11-28 | Smithkline Beecham Corp | Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby |
| US5690959A (en) | 1993-05-29 | 1997-11-25 | Smithkline Beecham Corporation | Pharmaceutical thermal infusion process |
| US5451409A (en) * | 1993-11-22 | 1995-09-19 | Rencher; William F. | Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends |
| JPH07223970A (ja) * | 1994-02-10 | 1995-08-22 | Tanabe Seiyaku Co Ltd | 消化管内適所放出製剤 |
| ES2559766T3 (es) | 1998-05-18 | 2016-02-15 | Takeda Pharmaceutical Company Limited | Comprimidos disgregables en la boca |
| CA2348871C (en) | 1998-11-02 | 2009-04-14 | John G. Devane | Multiparticulate modified release composition |
| US6340478B1 (en) | 1999-06-07 | 2002-01-22 | Bio Dar Ltd. | Microencapsulated and controlled-release herbal formulations |
| US6555139B2 (en) | 1999-06-28 | 2003-04-29 | Wockhardt Europe Limited | Preparation of micron-size pharmaceutical particles by microfluidization |
| AU6589200A (en) | 1999-09-10 | 2001-04-17 | Ranbaxy Laboratories Limited | Extended release formulation of etodolac |
| IN190974B (es) | 1999-09-10 | 2003-09-06 | Ranbaxy Lab Ltd | |
| KR100889069B1 (ko) | 1999-10-29 | 2009-03-17 | 유로-셀티크 소시에떼 아노뉨 | 서방성 하이드로코돈 제형 |
| CA2398555C (en) | 2000-01-27 | 2008-04-22 | Tanabe Seiyaku Co., Ltd. | Sustained release preparation and method for producing the same |
| JP4817562B2 (ja) | 2001-09-26 | 2011-11-16 | 東和薬品株式会社 | 長時間持続型ニフエジピン有核錠 |
| JP2003171277A (ja) * | 2001-12-07 | 2003-06-17 | Wyeth Lederle Japan Ltd | 薬物放出時間制御型固形製剤 |
| JP4790597B2 (ja) | 2003-04-24 | 2011-10-12 | ヤゴテック アーゲー | 規定されたコア幾何学的配置を有する遅延放出錠 |
| US20040241234A1 (en) | 2003-06-02 | 2004-12-02 | Alpharma, Inc. | Controlled release press-coated formulations of water-soluble active agents |
| US6869963B2 (en) * | 2003-07-11 | 2005-03-22 | Sandoz Ag | Stable pharmaceutical compositions containing an ACE inhibitor |
| EP1689367A1 (en) | 2003-10-21 | 2006-08-16 | Actavis Group HF | Pharmaceutical formulations containing quetiapine |
| EP1715856B1 (en) | 2003-12-31 | 2012-07-11 | Actavis Group PTC ehf. | Atomoxetine formulations |
| US20050220877A1 (en) * | 2004-03-31 | 2005-10-06 | Patel Ashish A | Bilayer tablet comprising an antihistamine and a decongestant |
| US20060008527A1 (en) | 2004-07-09 | 2006-01-12 | Yury Lagoviyer | Controlled phase composition technology as an improved process for protection of drugs |
| WO2006035313A1 (en) | 2004-09-29 | 2006-04-06 | Aurobindo Pharma Ltd | Solid unit dosage forms of 5-ht1 agonist |
| US20070129402A1 (en) | 2004-12-27 | 2007-06-07 | Eisai Research Institute | Sustained release formulations |
| US20080248107A1 (en) | 2005-08-24 | 2008-10-09 | Rubicon Research Pvt. Ltd. | Controlled Release Formulation |
| CN104161736A (zh) * | 2006-06-01 | 2014-11-26 | Msd消费保健品公司 | 包含去氧肾上腺素的缓释药物制剂 |
| KR100812538B1 (ko) | 2006-10-23 | 2008-03-11 | 한올제약주식회사 | 약물 제어방출형 메트포르민-글리메피리드 복합제제 |
| US9833510B2 (en) | 2007-06-12 | 2017-12-05 | Johnson & Johnson Consumer Inc. | Modified release solid or semi-solid dosage forms |
| CA2703365A1 (en) | 2007-10-25 | 2009-04-30 | Yuka Yamanouchi | Nifedipine-containing press coated tablet and method of preparing the same |
| JP4329947B1 (ja) * | 2009-01-20 | 2009-09-09 | ライオン株式会社 | 内服用錠剤 |
| GB201003766D0 (en) * | 2010-03-05 | 2010-04-21 | Univ Strathclyde | Pulsatile drug release |
| GB201003734D0 (en) * | 2010-03-05 | 2010-04-21 | Univ Strathclyde | Delayed prolonged drug delivery |
| GB201003731D0 (en) | 2010-03-05 | 2010-04-21 | Univ Strathclyde | Immediate/delayed drug delivery |
| CN103690545A (zh) | 2013-11-27 | 2014-04-02 | 河南中帅医药科技股份有限公司 | 口服泼尼松择时释放制剂及其制备方法 |
| GB201420311D0 (en) | 2014-11-14 | 2014-12-31 | Bio Images Drug Delivery Ltd | Pharmaceutical processing |
| GB201420300D0 (en) | 2014-11-14 | 2014-12-31 | Bio Images Drug Delivery Ltd | Tablet |
-
2014
- 2014-11-14 GB GBGB1420306.1A patent/GB201420306D0/en not_active Ceased
-
2015
- 2015-11-16 DK DK15797173T patent/DK3217964T3/da active
- 2015-11-16 EP EP15797173.0A patent/EP3217964B1/en active Active
- 2015-11-16 AU AU2015344838A patent/AU2015344838B2/en active Active
- 2015-11-16 WO PCT/GB2015/053471 patent/WO2016075495A1/en not_active Ceased
- 2015-11-16 SI SI201530991T patent/SI3217964T1/sl unknown
- 2015-11-16 RU RU2017116588A patent/RU2717574C2/ru active
- 2015-11-16 CN CN201580065549.1A patent/CN106999438A/zh active Pending
- 2015-11-16 US US15/526,655 patent/US10675247B2/en active Active
- 2015-11-16 MX MX2017006168A patent/MX379371B/es unknown
- 2015-11-16 ES ES15797173T patent/ES2755960T3/es active Active
- 2015-11-16 CA CA2967738A patent/CA2967738C/en active Active
- 2015-11-16 HU HUE15797173A patent/HUE047581T2/hu unknown
- 2015-11-16 KR KR1020177016405A patent/KR102253728B1/ko active Active
- 2015-11-16 PT PT157971730T patent/PT3217964T/pt unknown
- 2015-11-16 PL PL15797173T patent/PL3217964T3/pl unknown
- 2015-11-16 JP JP2017545002A patent/JP6774103B2/ja active Active
-
2017
- 2017-05-14 SA SA517381522A patent/SA517381522B1/ar unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT3217964T (pt) | 2019-11-26 |
| CN106999438A (zh) | 2017-08-01 |
| KR20170084282A (ko) | 2017-07-19 |
| US10675247B2 (en) | 2020-06-09 |
| RU2017116588A3 (es) | 2019-06-18 |
| CA2967738C (en) | 2021-07-06 |
| WO2016075495A1 (en) | 2016-05-19 |
| KR102253728B1 (ko) | 2021-05-21 |
| BR112017010070A2 (pt) | 2018-01-02 |
| SA517381522B1 (ar) | 2021-04-06 |
| JP2017534688A (ja) | 2017-11-24 |
| AU2015344838A1 (en) | 2017-06-01 |
| PL3217964T3 (pl) | 2020-03-31 |
| CA2967738A1 (en) | 2016-05-19 |
| US20170333355A1 (en) | 2017-11-23 |
| GB201420306D0 (en) | 2014-12-31 |
| DK3217964T3 (da) | 2019-11-25 |
| HUE047581T2 (hu) | 2020-05-28 |
| JP6774103B2 (ja) | 2020-10-21 |
| EP3217964B1 (en) | 2019-09-04 |
| HK1244432A1 (en) | 2018-08-10 |
| EP3217964A1 (en) | 2017-09-20 |
| ES2755960T3 (es) | 2020-04-24 |
| SI3217964T1 (sl) | 2020-02-28 |
| RU2717574C2 (ru) | 2020-03-24 |
| MX2017006168A (es) | 2017-09-12 |
| AU2015344838B2 (en) | 2020-10-08 |
| RU2017116588A (ru) | 2018-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12020550622A1 (en) | Kras g12c inhibitors | |
| MX2016014320A (es) | Composiciones de suspension de liberacion prolongada. | |
| EA201501024A1 (ru) | Составы с замедленным высвобождением, содержащие колхицин, и способы их применения | |
| IL273300A (en) | High dose valbenazine formulation and related preparations, methods and kits | |
| MX2020011478A (es) | Formas solidas de 2-(4-clorofenil)-n-((2-(2,6-dioxopiperidin-3-il) -1-oxoisoindolin-5-il)metil)-2,2-difluoroacetamida y sus composiciones farmaceuticas y usos. | |
| MX2018002462A (es) | Una composicion farmaceutica para reducir la grasa localizada y sus usos. | |
| PH12017502376A1 (en) | Oral solid formulation containing irinotecan and method of preparing the same | |
| PH12016501841A1 (en) | Immunosuppressant formulation | |
| ZA201807446B (en) | Improved drug formulations | |
| MY183068A (en) | Pharmaceutical formulation comprising antibody | |
| ECSP17018513A (es) | Derivados estabilizados de adrenomedulina y uso de los mismos | |
| IN2014KO00357A (es) | ||
| PH12016502544B1 (en) | Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor | |
| MX379371B (es) | Composiciones. | |
| EA201991286A1 (ru) | Твердая фармацевтическая композиция для перорального применения, содержащая тенофовир и эмтрицитабин | |
| MX2018014790A (es) | Formulacion combinada de tres compuestos antivirales. | |
| MX376853B (es) | Odorante osmanthus. | |
| EP3144005A4 (en) | Composition for preventing and treating male infertility, containing mixed herbal extract as active ingredient and use thereof | |
| MX391400B (es) | Formulaciones farmacéuticas de matriz que comprenden dimetilfumarato. | |
| PH12019500024A1 (en) | Pharmaceutical compositions | |
| MX2018005134A (es) | Formulacion de factor viii (fviii). | |
| GR20150100035A (el) | Φαρμακευτικο σκευασμα περιεχον απρεπιταντη και μεθοδος παρασκευης αυτου | |
| WO2016033549A3 (en) | (17-β)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE | |
| MA39009A (fr) | Compositions pharmaceutiques comprenant un agent actif | |
| MX2019000977A (es) | Composiciones farmacéuticas a base de curcumina y procedimientos para su fabricación. |